ScholarIQanswers from OpenAlex

Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics

PaperCitations, authors & open-access status

Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics have?

ScholarIQcitation count

Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics has 215 citations in the OpenAlex counts ScholarIQ stores.

When was Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics published?

ScholarIQyear

Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics has 2020 year in the ScholarIQ index.

What is the open-access status of Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics?

ScholarIQoa status

Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics has bronze oa status in the ScholarIQ index.

What is the DOI of Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics?

ScholarIQdoi

The DOI for Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics is on the source record.

What is the PMID of Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics?

ScholarIQpmid

The PMID for Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics is on the source record.

What is the OpenAlex record for Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics?

ScholarIQopenalex

The OpenAlex for Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial